Ryota Iwasawa

783 citations
7 papers · 642 indexed · h-index 5
Topics
Colorectal Cancer Treatments and Studies (3 papers)Mitochondrial Function and Pathology (2 papers)Gastric Cancer Management and Outcomes (2 papers)

In The Last Decade

Ryota Iwasawa

6 papers receiving 635 citations

Peers

Ryota Iwasawa
Comparison fields: 5 of 76
  • Molecular Biology 491
  • Cell Biology 181
  • Epidemiology 152
  • Physiology 85
  • Clinical Biochemistry 78
Replace Luis Carlos Tábara with:
Luis Carlos Tábara United Kingdom
Ryo Yonashiro Japan
Aleck W.E. Jones United Kingdom
Joo Hyun Lim South Korea
Mohamed A. Eldeeb Canada
Ai Ling Wang United States
Matthew Yoke Wui Ng Norway
Danny V. Jeyaraju Canada
Reiko Ban-Ishihara Japan
Yoshimasa Aoki Japan
Ryota Iwasawa relative to Luis Carlos Tábara United Kingdom Luis Carlos Tábara's profile →
Citations per field
00.5×1.5×
Luis Carlos Tábara · 1×
Citations per year

Countries citing papers authored by Ryota Iwasawa

Since Specialization
Citations

This map shows the geographic impact of Ryota Iwasawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryota Iwasawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryota Iwasawa more than expected).

Fields of papers citing papers by Ryota Iwasawa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ryota Iwasawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryota Iwasawa. The network helps show where Ryota Iwasawa may publish in the future.

Co-authorship network of co-authors of Ryota Iwasawa

This figure shows the co-authorship network connecting the top 25 collaborators of Ryota Iwasawa. A scholar is included among the top collaborators of Ryota Iwasawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ryota Iwasawa. Ryota Iwasawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
#WorkIndexed citations
1 1
2 0
3 4
4 99
5 45
6 65
7 428

About Ryota Iwasawa

Ryota Iwasawa is a scholar working on Cancer Research, Oncology and Immunology, having authored 7 papers that have together received 642 indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (3 papers), Mitochondrial Function and Pathology (2 papers) and Gastric Cancer Management and Outcomes (2 papers). The work is most often cited by research in Clinical Biochemistry (78 citations), Cell Biology (181 citations) and Molecular Biology (491 citations). Ryota Iwasawa has collaborated with scholars based in Spain, United Kingdom and Malaysia. Frequent co-authors include Evangelos Pazarentzos, Stefan Grimm, Christoph Datler, Anne‐Laure Mahul‐Mellier, Nabil Hajji, Sunniyat Rahman, Alan R. Boobis, Aleksandra Dąbrowska, José L. Venero and Mohammed K. Hankir. Their work appears in journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and The EMBO Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026